Neurocognitive effects of subanesthetic serial ketamine infusions in treatment resistant depression.
Zavaliangos-Petropulu A, McClintock SM, Khalil J, Joshi SH, Taraku B, Al-Sharif NB, Espinoza RT, Narr KL.
Zavaliangos-Petropulu A, et al.
J Affect Disord. 2023 Jul 15;333:161-171. doi: 10.1016/j.jad.2023.04.015. Epub 2023 Apr 14.
J Affect Disord. 2023.
PMID: 37060953
Free article.
Clinical Trial.
We performed an exploratory investigation of how ketamine treatment in TRD affects different cognitive domains and relates to antidepressant response. METHODS: Patients with TRD (N = 66; 30 M/35F; age = 39.5 11.1 years) received four ketamine infusions (0.5 mg/kg). ...Rela …
We performed an exploratory investigation of how ketamine treatment in TRD affects different cognitive domains and relates to antidepressant …